Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis

Langtao Hu1,2, Kai Yang1,2, Xing Mai1,2

  • 1Department of Nephrology, Hainan General Hospital, Haikou, China.

Insights

Dysfunctional histone deacetylases (HDACs) cause organ fibrosis. This study reveals HDAC3 exacerbates hyperuricemia-induced renal fibrosis by downregulating miR-19b-3p and upregulating SF3B3, suggesting therapeutic potential.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Dysfunctional histone deacetylases (HDACs) are implicated in organ fibrosis.
  • Hyperuricemia (HN)-induced renal interstitial fibrosis (RIF) is a significant health concern.
  • The specific role of HDAC3 in RIF and its underlying molecular mechanisms require elucidation.

Purpose of the Study:

  • To investigate the mechanism of HDAC3 in HN-induced RIF.
  • To explore the involvement of the microRNA-19b-3p/splicing factor 3b subunit 3 (miR-19b-3p/SF3B3) axis in this process.
  • To determine the therapeutic potential of targeting HDAC3 or miR-19b-3p in RIF.

Main Methods:

  • A rat model of HN-induced RIF was established.
  • Rats were treated with vectors to modulate miR-19b-3p or HDAC3 expression.
  • Key indicators of renal function (urine protein, UA, BUN, Scr) and fibrosis markers (α-SMA, TGF-β1, FN) were measured.
  • Renal tissue pathology and RIF index were assessed.
  • Expression and interaction of HDAC3, miR-19b-3p, and SF3B3 were analyzed.

Main Results:

  • HN rats exhibited elevated HDAC3 and SF3B3, and reduced miR-19b-3p in renal tissues.
  • Suppression of HDAC3 or augmentation of miR-19b-3p ameliorated RIF, improving renal function and reducing fibrosis markers.
  • HDAC3 was found to bind the miR-19b-3p promoter, regulating SF3B3 expression.
  • MiR-19b-3p depletion reversed the protective effects of HDAC3 suppression.

Conclusions:

  • HDAC3 plays a crucial role in promoting HN-induced RIF.
  • Depressed HDAC3 alleviates RIF by restoring miR-19b-3p and downregulating SF3B3.
  • Targeting the HDAC3/miR-19b-3p/SF3B3 axis offers a potential therapeutic strategy for RIF.

Related Concept Videos